Treatment as Prevention¨

During the annual Conference on Retroviruses and Opportunistic Infections to be held in Boston on February 22-25, Scientists and medical researchers seem to be in a more optimistic mood to resolve the haunting sexually transmitted disease – HIV/AIDS. During the event, researchers will be presenting emerging tools to control HIV/AIDS, which would include easy-to-use prevention

Known as Pre-exposure Prophylaxis, (PrEP), the pill would be taken by high-risk individuals, including homosexuals and bisexuals. The annual Conference on Retroviruses and Opportunistic Infections will be taking place in Boston this week, and new tools to prevent the transmission of HIV/AIDS will be presented that may be signifying that the end of the disease

From our current perspective, it is easy to forget that at the beginning of the AIDS pandemic, scientists did not even know the identity of the infectious agent causing a rare immunodeficiency. Rapid scientific advancement was needed to implement even basic public health measures such as laboratory-based testing to identify infected individuals and screen the

If you’ve been following or even skimming the news, no doubt you’ve heard about the current Zika outbreak, which has been drawing comparisons to the HIV pandemic (as well as the recent Ebola epidemic). So, what is Zika, and how does it compare with HIV? … We have known for a long time that HIV

Sunday, February 7th marks the second annual African, Caribbean and Black Canadian HIV/AIDS Awareness Day. The Canadian HIV/AIDS Black, African and Caribbean Network (CHABAC) and its partners started this day because we need to raise awareness of HIV, promote HIV prevention, and address HIV-related stigma and homophobia in Canada’s African, Caribbean and Black (ACB) communities.

New CDC Research Finds African Americans Are Less Likely to Receive Ongoing HIV Care Than white and Latino Americans African Americans living with HIV are less likely than white or Latino Americans to receive consistent, ongoing medical care, according to a new Centers for Disease Control and Prevention (CDC) report published today in Morbidity and

Tenofovir resistance is higher than expected in adult patients with HIV and treatment failure, according to a global evaluation published online January 28 in Lancet Infectious Disease. The higher-than-expected rates were particularly pronounced in low- to middle-income countries. The researchers also identified two new risk factors for tenofovir resistance and found that patients with tenofovir

It’s strange for me to be celebrating the return of science to Canada. If those who forget history are doomed to repeat it, what about those who fail science? My last high school science class was Chemistry 11, back in the ancient pre-internet era when kids still thought chemistry sets were cool. The only reason

The stigma related to HIV in the LGBT community on full display at CC16 plenary session CHICAGO — The grand ballroom in the Chicago Hilton has played host to many moments in American history — as the elevator trivia screens reminded everyone. But changing the commitment to the fight against HIV by the LGBTQ community